A notification about suspicious digital activity can lead to immediate and necessary action, highlighting the importance of understanding digital security. Platforms may restrict accounts due to unusual patterns, which can…
India and Italy have signed an agreement to enhance scientific collaboration, focusing on quantum technology, artificial intelligence, and biotechnology. This partnership builds on 150 past collaborative projects and aims to…
The Trump administration's proposed reduction in federal payments poses a significant threat to research universities like Virginia Tech, with potential losses reaching $18 million annually. Indirect costs, essential for maintaining…
The global biotechnology race is intensifying, with the U.S. and China competing for dominance, impacting national security, economic balance, and technological progress. The National Security Commission on Emerging Biotechnology warns…
Edesa Biotech welcomes Peter J. Weiler as the new financial leader, effective May 1, 2025, to invigorate the company's strategic ambitions. Weiler's robust background includes roles at Exzell Pharma, Cipher…
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer effective May 1, 2025, succeeding Stephen Lemieux. Weiler brings extensive experience from his leadership role at Exzell Pharma and holds…
Edesa Biotech appoints Peter J. Weiler as the new Chief Financial Officer, effective May 1, 2025, succeeding Stephen Lemieux. Weiler's extensive background spans key roles at Exzell Pharma, Biosyent Inc.,…
Wacker Biotech and RNAV8 Bio have formed a strategic partnership to advance mRNA therapeutics. Wacker Biotech brings its expertise in microbial fermentation, processing up to 650 liters of material, to…
Wacker Biotech and RNAV8 Bio are collaborating to revolutionize mRNA-based therapies. Wacker Biotech brings expertise in pDNA/mRNA manufacturing and lipid nanoparticle (LNP) formulation. RNAV8 Bio specializes in optimizing noncoding mRNA…
The biotech and pharmaceutical industries face significant layoffs as companies like Nkarta and Alector realign strategies, aiming for operational efficiency and innovation. Major players, including Novartis, are restructuring to align…